Envveno Medical Corp income statement

In fiscal 2019, Envveno Medical Corp reported revenue of $31,243, down 83.3% on the year before, operating income of −$7.7m (a -24566.5% margin) and net income of −$7.6m, or −$423.50 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Envveno Medical Corp: income statement, annual
Fiscal year	2017Dec 2017	2018Dec 2018	2019Dec 2019
Revenue	0	0	0
Cost of revenue	0	—	—
Gross profit	0	0	—
Research and development	1	1	2
Selling, general and administrative	5	6	5
Operating income	−6	−8	−8
Interest expense	0	0	—
Net interest income	—	0	−0
Net income	−8	−13	−8
Diluted EPS	−$1181.25	−$61.25	−$423.50
Diluted shares (average)	7m	11m	18m
EBITDA	−6	−8	−8

US$ thousands unless shown otherwise. Fiscal quarters.

Envveno Medical Corp: income statement, quarterly
Quarter	2018 Q1Mar 2018	2018 Q2Jun 2018	2018 Q3Sept 2018	2018 Q4Dec 2018	2019 Q1Mar 2019	2019 Q2Jun 2019	2019 Q3Sept 2019	2019 Q4Dec 2019
Revenue	31	83	42	30	31	0	0	0
Gross profit	—	83	42	30	31	—	—	—
Research and development	240	280	425	293	313	428	677	788
Selling, general and administrative	1,247	2,915	1,105	1,217	1,301	1,532	1,157	922
Operating income	−1,456	−3,112	−1,488	−1,799	−1,582	−1,960	−1,834	−2,299
Interest expense	—	106	0	0	—	—	—	—
Net interest income	210	112	−7	−17	−9	−14	−19	−8
Net income	−4,747	−5,045	−1,468	−1,782	−1,574	−1,946	−1,815	−2,291
Diluted EPS	−$700.00	−$927.50	−$113.75	−$1.75	−$4.55	−$4.55	−$3.50	−$411.25
EBITDA	−1,423	−3,079	−1,454	−1,765	−1,560	−1,932	−1,799	−2,260

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Envveno Medical Corp's SEC filings (10-K and 10-Q), retrieved November 1, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Envveno Medical Corp.